Abstract
Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV,
| Original language | English |
|---|---|
| Journal | Chest |
| Volume | 110 |
| Issue number | 4 SUPPL. |
| State | Published - Oct 1996 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pulmonary and Respiratory Medicine
Cite this
Pharmacoeconomic evaluation of COPD : Stratification of outcomes and costs according to initial drug therapy. / Hilleman, Daniel E.; Wadibia, E. C.; Shinn, B.
In: Chest, Vol. 110, No. 4 SUPPL., 10.1996.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Pharmacoeconomic evaluation of COPD
T2 - Stratification of outcomes and costs according to initial drug therapy
AU - Hilleman, Daniel E.
AU - Wadibia, E. C.
AU - Shinn, B.
PY - 1996/10
Y1 - 1996/10
N2 - Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV,
AB - Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV,
UR - http://www.scopus.com/inward/record.url?scp=33746398668&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33746398668&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:33746398668
VL - 110
JO - Chest
JF - Chest
SN - 0012-3692
IS - 4 SUPPL.
ER -